This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 13, 2013

Home   Contact

 


TOP STORIES

No, There Won't Be a Doctor Shortage
The New York Times
In just over a decade the United States will need 130,000 more doctors than medical schools are producing. So says the Association of American Medical Colleges, which warns of a doctor shortage that will drive up wait times, shorten office visits and make it harder for Americans to access the care they need.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Session Recordings from WSAUA's 2013 Annual Meeting Now Available Online at No Charge - Compliments of Western Section AUA!
WSAUA
Experience educational content from the WSAUA’s 2013 Annual Meeting Scientific Sessions. We’re excited to offer you complimentary access to the session recordings from the conference through the WSAUA Live Learning Center.

Recorded sessions make great training tools and provide a comprehensive recap of all the valuable information that was shared at the conference. Catch up on sessions you missed and review industry information at your convenience. If you were unable to attend the event, here’s your chance to find out what you missed. Session recordings through the Live Learning Center keep you up-to-date on the latest industry education so you can continue your professional development year-round. Visit the WSAUA Live Learning Center to access the session recordings.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Physician payment reform matters to cancer patients
The Hill
Why should patients care about how physicians are paid? Because the way we as a country, and Medicare as the largest payer, compensate physicians directly affects the care patients receive. Changes to the way physicians are paid are on the horizon, as our current system is not sustainable for physicians, patients, or taxpayers. Patients must have a voice in debates about Medicare payment and the way health care is reimbursed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Without Way to Pay for SGR Repeal, Is Optimism in Vain?
HealthLeaders Media
Repeal of the Medicare Sustainable Growth Rate has clear momentum, but with 2013 winding down and the $139 billion price tag still unresolved, physicians could be facing yet another short-term fix. There is unmistakable momentum in Congress for repealing the Medicare Sustainable Growth Rate (SGR), but as 2013 winds down with Congress eyeing the holiday recess, physicians could be facing the possibility of yet another short-term fix.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Urinary Tract Infection Agent Yields Positive Phase III Study Results
Urology Times
Ceftolozane/tazobactam, an investigational antibiotic, showed positive top-line results in a pivotal phase III clinical trial of the drug’s use in complicated urinary tract infections (cUTI), Cubist Pharmaceuticals, Inc. reported. Ceftolozane/tazobactam met its primary endpoint of statistical non-inferiority compared to levofloxacin (Levaquin) (10 percent non-inferiority margin).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The Most Polarizing Topics in Healthcare IT
HealthLeaders Media
Seven healthcare IT issues that divide IT leaders, users, and patients, including Healthcare.gov, Epic Systems, ICD-10 and SNOWMED CT, and the BYOD trend. It's time for those stories that look back at 2013. What better place to start but with those healthcare IT issues that divide us and create lots of topics for journalists like me to pick apart and try to put back together.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Testosterone May Ease Inflammatory Bowel Disease in Hypogonadal Men
Renal & Urology News
Normalization of testosterone (T) levels improved Crohn's disease in hypogonadal men in a prospective, observational registry study, researchers reported at the Men's Health World Congress. The study included 71 hypogonadal men with Crohn's disease and two with colitis ulcerosa. The patients received treatment with parenteral testosterone undecanoate on day 1, after six weeks, and every 12 weeks thereafter for up to 75 months.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Protein May Be Marker for Aggressive Prostate Cancer
Urology Times
British scientists have discovered that the presence of a specific protein can distinguish between indolent and aggressive prostate cancer. Their study, which was published online in Oncogene found much higher levels of the protein, NAALADL2, in prostate cancer tissue compared with healthy tissue. The difference was especially marked in aggressive prostate cancer tumors and cancer cells that had already metastasized.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


No Kidney Injury Risk From High-Potency Statins
Renal & Urology News
A pooled analysis of two large randomized clinical trials found no increased risk of kidney injury with the use of high-potency statins compared with moderate-potency statins in patients with acute coronary syndromes (ACS). The analysis was presented by Dr. Amy A. Sarma, at the American Heart Association's Scientific Sessions 2013.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Peyronie's Agents Meets Phase III Study Endpoints
Urology Times
Data from phase III studies of collagenase clostridium histolyticum (CCH [XIAFLEX]) showed that the agent met primary endpoints related to Peyronie's disease (PD) curvature and symptoms, and that it is effective and safe in certain subgroups of men with PD, according to Auxilium Pharmaceuticals, Inc.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Kidney Cancer Prognosis Linked to Blood Type
Renal & Urology News
Blood group O in patients with renal cell carcinoma (RCC) is associated with a lower risk of lymph node metastases but a higher risk of bilateral disease, according to researchers. It is not associated with survival. A team led by Tobias Klatte, MD, of the Medical University of Vienna in Austria reviewed data from 556 patients who underwent surgery for RCC to evaluate the relationship between blood groups and clinical and pathologic variables. Subjects had a median follow-up of 39 months.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


'Country Doctor of the Year' Embraces Challenges of Rural Medicine
HealthLeaders Media
Since 1992 the physician staffing company Staff Care has honored a Country Doctor of the Year. The award is given to one physician each year, but it could easily be awarded to thousands of dedicated physicians serving rural America.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA Approves New Drug for Peyronie's Disease
Renal & Urology News
The FDA has given its first-ever approval of a new medication to treat Peyronie's disease. The agency's approval of collagenase clostridium histolyticum (Xiaflex) calls for for a maximum of four treatment cycles. Each cycle consists of two injections and one penile remodeling procedure performed by a healthcare professional.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 

WSAUA Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Lee Escobedo, Content Editor, 469.420.2663  
Contribute news

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Western Section AUA Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Dec. 13, 2013
Dec. 5, 2013
Nov. 28, 2013
Nov. 21, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063